Global Pharmaceuticals & Biotech ROE over 20

Johnson & Johnson

Market Cap: US$564.0b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Merck

Market Cap: US$294.1b

Operates as a healthcare company worldwide.

Gilead Sciences

Market Cap: US$170.8b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Bristol-Myers Squibb

Market Cap: US$122.9b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Vertex Pharmaceuticals

Market Cap: US$112.2b

Operates as a biotechnology company in the United States, Europe, and internationally.

Alnylam Pharmaceuticals

Market Cap: US$41.1b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Waters

Market Cap: US$32.2b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

IQVIA Holdings

Market Cap: US$29.6b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Illumina

Market Cap: US$20.4b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Incyte

Market Cap: US$19.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Exelixis

Market Cap: US$11.7b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Arrowhead Pharmaceuticals

Market Cap: US$9.7b

Develops medicines for the treatment of intractable diseases in the United States.

ACADIA Pharmaceuticals

Market Cap: US$3.8b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Catalyst Pharmaceuticals

Market Cap: US$3.2b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

ADMA Biologics

Market Cap: US$2.6b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Organon

Market Cap: US$2.5b

Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.

Phibro Animal Health

Market Cap: US$2.3b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Bausch Health Companies

Market Cap: US$2.2b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Aurinia Pharmaceuticals

Market Cap: US$2.1b

A biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.

Innoviva

Market Cap: US$1.8b

Operates as a biopharmaceutical company in the United States and internationally.

Anbio Biotechnology

Market Cap: US$1.2b

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

Collegium Pharmaceutical

Market Cap: US$1.1b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Theravance Biopharma

Market Cap: US$887.2m

A biopharmaceutical company, develops and commercializes medicines in the United States.

CorMedix

Market Cap: US$584.2m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

XOMA Royalty

Market Cap: US$473.2m

Operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia.

Puma Biotechnology

Market Cap: US$380.0m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Abeona Therapeutics

Market Cap: US$313.8m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

Compugen

Market Cap: US$266.6m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Keros Therapeutics

Market Cap: US$230.1m

A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.

Oramed Pharmaceuticals

Market Cap: US$156.9m

Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.